Farms.com Home   News

EU Considers New Tariffs on US Soybeans, Could Raise Meat Prices

By Sead Dedovic

After relations between the European Union and the USA worsened due to the customs war, the EU announced the possibility of introducing tariffs on agricultural products from the USA. This decision could bring massive changes in the price of meat in Europe, said analysts from the German Handelsblatt.

Trade wars between the two economic powers have been causing difficulties for everyone for a long time. If the EU decided to introduce tariffs on American soybeans, there could be disruptions in meat production in Europe. Namely, soy is the main ingredient of livestock feed, and the USA is also the main supplier of this product. Because of this, any increase in prices could lead to consequences and reactions.

Many experts are already predicting what this could bring.

Changes in production

One of the major problems in this trade environment is that there is simply not enough soybean production in Europe to meet the needs of agricultural producers. Although soybeans from Brazil are also imported, the US is the main player in the market.

The introduction of tariffs could lead to an increase in the cost of meat production, as farmers would have to purchase more expensive raw materials or turn to alternatives that are not always available in large enough quantities.

The German Meat Industry Association has already warned that an increase in soybean prices would have an incredible impact on meat prices. If tariffs were indeed introduced, it would first affect livestock farmers, and then the prices would be passed on to end products, such as meat products.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.